Erwan Barre is a Partner (Foreign Lawyer) at RHTLaw Taylor Wessing and the Firm’s Deputy Head of Corporate Practice. He joined RHTLaw Taylor Wessing in 2015 after practicing for sixteen years with Sullivan & Cromwell and Paul Hastings, two leading US law firms, in Paris and New York. Focused on corporate transactions, Erwan has extensive experience representing clients across many industries, with an emphasis in the Technology and Life Science industries.

He also has management experience, being a co-founder of Vaximax, a biotech company.

Erwan has been involved in many M&A, joint venture, capital markets and financing projects in Asia, Europe and the US, including several game changing transactions. Most of these deals were cross-border. His transactional expertise is based on leading over 60 deals, representing in the aggregate more than US$20 billion. 15 of his deals exceeded US$ 500 million in value with several in excess of US$ 1 billion. 60% of his transactions involved TMT (telecommunications, media and technology) and life science companies. He has also represented clients in other industries, including aerospace, real estate, hospitality and energy.

His clients include blue chip names as well as promising start-ups and many leading investment banks.

He has been regularly recognised as a leading practitioner in his field by professional publications, such as Chambers and Legal 500.

Erwan holds an MBA from the Neoma (ESC Reims) Business School in France (1990), a pre-doctoral degree (DEA) in business law from the Pantheon-Sorbonne (Paris I) University (1993), and an LL.M. degree from Columbia University in the US (1996). Erwan has worked in Singapore, Paris, New York and London.

Partner (Foreign Lawyer)
LL.M (Columbia U, New York), DEA (Panthéon-Sorbonne U. Paris), MBA (ESC Reims – Neoma), Attorney admitted in Paris (France) and New York (USA), Foreign Lawyer (Singapore)
Corporate Transactions
Public and Private M&A
Private Equity Investments
Collaborations and Joint Ventures
Equity Finance Transactions (Public Offerings and Private Placements)


Direct: +65 6381 6386
Fax : +65 6381 6869